This session provides an overview of simple analgesia. It explains the pharmacokinetic and pharmacodynamic properties of paracetamol and aspirin. It will describe mechanisms of action and highlight clinical considerations for safe use of these drugs.
This session will provide a brief overview of the history of NSAIDs, their chemistry, and a profile of their uses. Their side-effects, mechanism of action and interaction with different isoforms of cyclo-oxygenase will also be discussed.
This session is an introduction to opioid drugs. It describes the classification of different opioid receptors, their common mechanisms of action and their location. Their clinical effects, physiochemical properties and unwanted effects are also introduce
This session considers the pharmacology of morphine and other opioids. It covers analgesic efficacy and side effects, pharmacokinetics (which takes in bioavailability, lipid solubility and half-life) and inter-individual variability in pharmacodynamics an
This session describes the pharmacology and uses of weak opioids such as codeine, as well as partial agonist and mixed agonist/antagonist drugs, and lists the problems associated with their use. It also examines the pharmacology and use of μ receptor a
This session provides an overview of the structure and function of the skeletal neuromuscular junction. It identifies sites at which drugs and toxins interrupt signal transmission between motor nerves and the mechanism of excitation-contraction coupling.
This session explores the pharmacokinetic and pharmacodynamic properties of the aminosteroid neuromuscular blocking agents (NMBAs). It explores: the relationship between the chemical structure of these agents, their potency and their route of elimination;
This session describes the benzylisoquinolinium neuromuscular blocking agents, including their pharmacological properties and cardiovascular side-effects.
